Patent & Trade Secrets Law Bill Richardson and Ariel Neuer University of Toronto February 28, 2012.

Slides:



Advertisements
Similar presentations
Disclaimer: The information provided by the USPTO is meant as an educational resource only and should not be construed as legal advice or written law.
Advertisements

Points Relied On Points and Critique Dean Ellen Suni Fall 2013 These materials are for teaching purposes only. The law is probably incorrect and is solely.
Chapter 5: Mutual Assent
Patent Law Overview. Outline Effect of patent protection Effect of patent protection Substantive requirements for patent protection Substantive requirements.
Incorporation by Reference
INTRODUCTION TO PATENT RIGHTS The Business of Intellectual Property
Canada and the World J. Sheldon Hamilton, Smart & Biggar Tony Creber, Gowlings Donald Cameron, Bereskin & Parr Norman Siebrasse, UNB (moderator)
1 35 USC 112, 1 st paragraph enablement Enablement Practice in TC 1600 Deborah Reynolds, SPE
The America Invents Act (AIA) - Rules and Implications of First to File, Prior Art, and Non-obviousness -
September 14, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December.
Filing Compliant Reexam Requests Andy Kashnikow SPE, Central Reexamination Unit Andy Kashnikow SPE, Central Reexamination Unit June, 2010.
JPO’s Reliance on Experimental Results in Patent Applications -From the Aspect of Requirements for Description of Claims and Specification- JPAA International.
Patents Copyright © Jeffrey Pittman. Pittman - Cyberlaw & E- Commerce 2 Legal Framework of Patents The U.S. Constitution, Article 1, Section 8:
Determining Obviousness under 35 USC 103 in view of KSR International Co. v. Teleflex TC3600 Business Methods January 2008.
Intellectual Property Boston College Law School February 25, 2008 Patent - Utility.
by Eugene Li Summary of Part 3 – Chapters 8, 9, and 10
Patent Overview by Jeff Woller. Why have Patents? Patents make some people rich – but, does that seem like something the government should protect? Do.
Patents 101 April 1, 2002 And now, for something new, useful and not obvious.
SECTION 101 OF THE PATENT LAW Describes what is patentable subject matter: "Whoever invents or discovers any new and useful process, machine, manufacture,
Secondary Use Patents: An international and Canadian perspective E. Richard Gold James McGill Professor, McGill Faculty of Law Secondary Use Pharmaceutical.
GENERAL TYPES OF AUDIT REPORTS
Study on the Sufficiency of Disclosure (SCP/22/4) Standing Committee on the Law of Patents (SCP) Twenty- second session (July 27 to 31, 2015) Presentation.
Intellectual Property
Chapter 4: Consideration (Bargained for Exchange)
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA AN OVERVIEW OF PATENT PROTECTION IN ZAMBIA.
Motion for Summary Judgment The Keys to Success. How does this work?  Summary judgments are governed by Rule 166(a) of the Texas Rules of Civil Procedure.
Utility Requirement in Japan Makoto Ono, Ph.D. Anderson, Mori & Tomotsune Website:
Car Theft and the Insurance Contracts Act 1984 (Cth)
Broadening the Scope of the Claims in Gene Therapy Applications Deborah Reynolds Detailee, TCPS
Utility Requirement in Canada. 2 Section 2 of the Patent Act: “invention” means any new and useful art, process, machine, manufacture or composition of.
Impact of US AIA: What Really Changed? 1 © AIPLA 2015.
1 Patent Law in the Age of IoT The Landscape Has Shifted. Are You Prepared? 1 Jeffrey A. Miller, Esq.
The Patent Document II Class Notes: January 23, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
Patent Law Presented by: Walker & Mann, LLP Walker & Mann, LLP 9421 Haven Ave., Suite 200 Rancho Cucamonga, Ca Office.
Patents III Novelty and Loss of Rights Class 13 Notes Law 507 | Intellectual Property | Spring 2004 Professor Wagner.
PatentEng-Berkeley-Lavian Week 6: Validity and Infringement 1 Patent Engineering IEOR 190G CET: Center for Entrepreneurship &Technology Week 6 Dr. Tal.
1 Canada: The Statutory Basis for and Judicial Application of the Utility Requirement Steven B. Garland Comparative Intellectual.
July 18, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December 10,
1 Written Description Analysis and Capon v. Eshhar Jeffrey Siew Supervisory Patent Examiner AU 1645 USPTO (571)
Hamre, Schumann, Mueller & Larson, P.C U.S. Patent Claims By James A. Larson.
New Sections 102 & 103 (b) Conditions for Patentability- (1) IN GENERAL- Section 102 of title 35, United States Code, is amended to read as follows: -`Sec.
Overview Validity of patent hinges on novelty, utility, and non-obviousness Utility generally not an issue Pre-suit investigation focuses on infringement,
1 Demystifying the Examination of Stem Cell-Related Inventions Remy Yucel, Ph.D. Supervisory Patent Examiner Technology Center 1600 United States Patent.
Examining Claims for Compliance with 35 U.S.C. 112(a): Part II – Enablement Focus on Electrical/Mechanical and Computer/Software-related Claims August.
Patentable Subject Matter Donald M. Cameron. 2 Patents: The Bargain Public: gets use of invention after patent expires Inventor/Owner: gets limited monopoly.
© 2008 International Intellectual Property June 16, 2009 Class 2 Introduction to Patents.
1 Patent Claim Interpretation under Art. 69 EPC – Should prosecution history be used to interpret the patent? presented at Fordham 19th Annual Conference.
Double Patenting Deborah Reynolds SPE Art Unit 1632 Detailee, TC1600 Practice Specialist
Patents II Disclosure Requirements Class 12 Notes Law 507 | Intellectual Property | Spring 2004 Professor Wagner.
Patents and the Patenting Process Patents and the Inventor’s role in the Patenting Process.
Nuts and Bolts of Patent Law presented by: Shamita Etienne-Cummings April 5, 2016.
Patents 101 March 28, 2006 And now, for something new, useful and not obvious.
Professional Engineering Practice
Patents 101 March 28, 2006 And now, for something new, useful and not obvious.
INTELECTUAL PROPERTY RIGHTS
PATC Module 2 – Infringement/Validity
PATC Module 2 – Infringement/Validity
PATC Module 2 – Infringement/Validity
PATC Module 2 – Infringement/Validity
PATC Module 2 – Infringement/Validity
PATC Module 2 – Infringement/Validity
Prosecution Luncheon Patent August 2017
OTHER INVALIDITY CHALLENGES
Lord Neuberger in Actavis v Eli Lilly [2017] RPC 21, para. 57.
Global Innovation Management Workout on Writing a Patent
Law 677 | Patent Law | Spring 2003
Patents II Disclosure Requirements
PATC Module 2 – Infringement/Validity
Esomeprazole SCC AstraZeneca v Apotex, 2017 SCC 36.
FCA DECISIONS – CONSTRUCTION AND THE SKILLED PERSON
Presentation transcript:

Patent & Trade Secrets Law Bill Richardson and Ariel Neuer University of Toronto February 28, 2012

2 Other Attacks on Validity

3 Sufficiency (1/4) PatenteeSociety Gain -Monopoly over invention -Disclosure of the nature and working of the invention -Incentive for people to invent Price -“hard coinage” of disclosure -Grant of monopoly restricts others Description of the invention is quid pro quo

4 Sufficiency (2/4) Patent Act 27. (3) The specification of an invention must (a) correctly and fully describe the invention and its operation or use as contemplated by the inventor; (b) set out clearly the various steps in a process, or the method of constructing, making, compounding or using a machine, manufacture or composition of matter, in such full, clear, concise and exact terms as to enable any person skilled in the art or science to which it pertains, or with which it is most closely connected, to make, construct, compound or use it; …

5 Sufficiency (3/4) Only 2 questions relevant to type of information required under 27(3): –What is your invention? –How does it work?

6 Sufficiency (4/4) A question of mixed fact and law Key issue: Can POSITA successfully practice the invention? simple experimentation  OK “inventive” experimentation  Not OK.

7 Utility

8 Utility (1/7) Derives from s. 2 of Patent Act: “‘invention’ means any new and useful art, process, machine, manufacture or composition of matter, or any new and useful improvement in any art, process, machine, manufacture or composition of matter;”

9 Utility (2/7) To establish inutility, the patent must either: –not operate at all or –not do what the specification promises it will do Disclosure and date of invention important (see below)

10 Utility (3/7) Where no result promised, a “mere scintilla” of utility will suffice However, if a result is promised, utility will be measured against that promise –The question is whether the invention does what the patent promises it will do.

11 Utility (4/7) There must have been a demonstration of utility by the Canadian filing date However, no requirement to prove utility in patent so long as can prove it in response to legal challenge Otherwise, there must have been a “sound prediction” of the utility by the Canadian filing date Premise of sound prediction: No patent for a lucky guess

12 Utility (5/7) Sound prediction requirements: (1) there must be a factual basis for the prediction; (2) the inventor must have an articulable line of reasoning (3) disclosure of the factual basis and line of reasoning must be in the patent

13 Utility (6/7) Dates and disclosure are important Was utility established as of filing date? –(a) if so, no requirement to disclose support for utility in patent –(b) if not  sound prediction  patent must disclose factual data on which the prediction is based and line of reasoning

14 Utility (7/7) If a patent claim includes within its scope subject matter lacking utility (“inoperable species”), the entire claim is invalid Entire claim Inoperable species

15 Ambiguity

16 Ambiguity (1/4) Patent Act, S. 27(4) “The specification must end with a claim or claims defining distinctly and in explicit terms the subject-matter of the invention for which an exclusive privilege or property is claimed.”

17 Ambiguity (2/4) Claims must be: sufficiently explicit so as to inform the reader as to what is within and what is not within its ambit

18 Ambiguity (3/4) Claim must NOT be: –unclear or given insufficient direction as to its boundaries (fences) –vague –interpreted in more than one way, so that it would be impossible for anyone to know whether something falls within

19 Ambiguity (4/4) A claim is construed according to principles of claims construction enunciated by the S.C.C. (see Free World Trust) The language of the claims must be read in light of the specification as a whole, although only the language of the claims that determines the scope

20 Overbreadth

21 Overbreadth (1/2) Patent Rules, S. 84 “The claims shall be clear and concise and shall be fully supported by the description independently of any document referred to in the description.” See also Patent Act s. 27(3) and (4)

22 Overbreadth (2/2) Patentee can: –Claim less than that which is disclosed Patentee cannot –Claim more than that which is disclosed  overbreadth

23 Section 53

24 Section 53 (1/5) Patent Act, 53(1): “A patent is void if any material allegation in the petition of the applicant in respect of the patent is untrue, or if the specification and drawings contain more or less than is necessary for obtaining the end for which they purport to be made, and the omission or addition is wilfully made for the purpose of misleading.”

25 Section 53 (2/5) Allegations under s. 53 implicate the notion of fraud The onus is on the party alleging an intention to mislead to prove it Allegation should not be made lightly, without a sufficient evidentiary foundation There are serious cost consequences to an unproven allegation

26 Section 53 (3/5) (1) Untrue material allegation plain reading: no requirement for wilfulness Some cases have discussed wilfulness when considering this part of the section Cases suggest that the focus is on materiality An untrue statement, even if made without intention, will void a patent if it is material.

27 Section 53 (4/5) (2) Wilfully misleading omission/addition Proof of wilfulness is an essential element Can be made out by evidence from which intent to mislead can be inferred

28 Section 53 (5/5) Truth of the allegations considered as of the time of issue of the patent.

29 Overlap of Grounds “ I have deliberately bundled all of the topics listed in the title of this portion of these Reasons, “Anticipation/Obviousness/Sound Prediction/Sufficiency of Disclosure” together. There is one issue to be considered namely, the validity of the ’356 patent. There is a tendency in the jurisprudence to pigeonhole arguments respecting validity into certain categories such as “anticipation” or “obviousness” and so forth. Each category has collected about itself an accumulation of jurisprudence. Each category tends to be argued separately creating, on occasion, contradictions, inconsistencies and gaps.” Eli Lilly Canada Inc. v. Apotex Inc., 2008 FC 142 at para 64 (Hughes J)

30 Miscellany –Disclaimer: –Patentee may amend a patent to claim less than what was claimed in the original patent –Must arise through mistake, accident or inadvertence –Re-examination: –Any person can request that patent claims be re-examined by the patent office –Rarely used in practice, since patentee has ability to amend claims –Maintenance fees: –A patent can lapse if patentee fails to pay fees in a timely manner and remedial action is not taken

31 Case studies –Why are these claims/patents invalid? –Patent for pills that promise to lengthen body parts or to burn away 20 lbs in 2 weeks –Patent for chemical process; however key step in process is omitted in disclosure

32 Case Study #2 (Utility) News report: mice suffering from fur loss regained their fur when injected with compound (“astressin-B”) Would a claim for treatment of hair loss in humans based on the mouse study be valid?